WallStSmart

nVent Electric PLC (NVT)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

nVent Electric PLC generates 34% more annual revenue ($4.33B vs $3.22B). WST leads profitability with a 16.9% profit margin vs 11.4%. NVT appears more attractively valued with a PEG of 1.76. WST earns a higher WallStSmart Score of 65/100 (C+).

NVT

Buy

55

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 2.7Quality: 5.0

WST

Buy

65

out of 100

Grade: C+

Growth: 7.3Profit: 8.0Value: 2.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NVTSignificantly Overvalued (-72.1%)

Margin of Safety

-72.1%

Fair Value

$65.53

Current Price

$173.39

$107.86 premium

UndervaluedFair: $65.53Overvalued
WSTSignificantly Overvalued (-32.4%)

Margin of Safety

-32.4%

Fair Value

$185.95

Current Price

$322.30

$136.35 premium

UndervaluedFair: $185.95Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVT1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
53.5%10/10

Revenue surging 53.5% year-over-year

WST4 strengths · Avg: 9.0/10
EPS GrowthGrowth
56.1%10/10

Earnings expanding 56.1% YoY

Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.7%8/10

Strong operational efficiency at 21.7%

Revenue GrowthGrowth
21.0%8/10

Revenue surging 21.0% year-over-year

Areas to Watch

NVT3 concerns · Avg: 2.7/10
PEG RatioValuation
1.764/10

Expensive relative to growth rate

P/E RatioValuation
58.8x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-59.5%2/10

Earnings declined 59.5%

WST2 concerns · Avg: 2.0/10
PEG RatioValuation
3.142/10

Expensive relative to growth rate

P/E RatioValuation
43.5x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NVT

The strongest argument for NVT centers on Revenue Growth. Revenue growth of 53.5% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on EPS Growth, Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 21.7%. Revenue growth of 21.0% demonstrates continued momentum.

Bear Case : NVT

The primary concerns for NVT are PEG Ratio, P/E Ratio, EPS Growth. A P/E of 58.8x leaves little room for execution misses.

Bear Case : WST

The primary concerns for WST are PEG Ratio, P/E Ratio. A P/E of 43.5x leaves little room for execution misses.

Key Dynamics to Monitor

NVT carries more volatility with a beta of 1.32 — expect wider price swings.

NVT is growing revenue faster at 53.5% — sustainability is the question.

NVT generates stronger free cash flow (49M), providing more financial flexibility.

Monitor ELECTRICAL EQUIPMENT & PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WST scores higher overall (65/100 vs 55/100), backed by strong 16.9% margins and 21.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

nVent Electric PLC

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

nVent Electric plc designs, manufactures, markets, installs and services electrical connection and protection products in the United States, Canada, Western and Eastern Europe included in the European Union, China, Eastern Europe not included in the European Union, America Latin, Middle East, Southeast Asia, Australia and Japan. The company is headquartered in London, the United Kingdom.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?